Trodelvy 180 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FM8WY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,901
Award facts
- Contract value 100% obligated
- $17,901.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $17,901.20 delivery order to Amerisourcebergen Drug Corp on April 20, 2026, for 180 mg vials of Trodelvy (sacituzumab govitecan), a specialty oncology pharmaceutical.
The order is placed under a DLA Troop Support Medical indefinite delivery contract. Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure with an ultimate completion date of May 11, 2026. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26FM8WY?
SPE2DR26FM8WY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 20, 2026.
How much is contract SPE2DR26FM8WY worth?
The government has obligated $17,901 on SPE2DR26FM8WY.
Is contract SPE2DR26FM8WY an order under another contract?
Yes. SPE2DR26FM8WY is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM8WY competed?
The extent of competition for SPE2DR26FM8WY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award